Eurofins Biomnis code

CHPBM

Synonyms

• Chlamydia

Specialty

Infectious

Clinical significance

Chlamydophila pneumoniae can cause upper and lower respiratory infections. Infection with Chlamydophila pneumoniae can be manifested by atypical pneumonia, which is often protracted and can be serious in children and elderly patients. The bacteria may remain in a latent state. Diagnosis is possible at the onset of the disease by gene amplification (PCR) of respiratory samples. A positive PCR result may be associated with carriage. This result must be checked against the clinical-biological context. Serology is often difficult to interpret, given the seroprevalence in the general population. In case of recent infection, seroconversion and/or the presence of specific IgM antibodies may help in the diagnosis.

Preanalytics

• 1 mL :
• Nasopharyngeal swab (aspiration or swabbing), respiratory swab (aspiration, bronchial swab, BAL, etc.), pleural fluid, CSF (0.5 mL minimum)
•   Refrigerated

• A tube specifically for this analysis : No

Further information

[To be translated]
The use of the S14UK transport bag is Mandatory.
Swab samples require the use of a transport medium (viral) supplied in kit K1.
Samples (other than swabs) must be sent as they are, in sterile bottles, without transport medium.

Specific equipment available

• S14: Special mycobacteria transport bags are to be used

Documents to download

• information note (N23-INTGB)

Methodology

Real-time PCR

Turnaround time

3 days